- Home
- WALD vs INBX Comparison
WALD vs INBX Comparison
Compare WALD & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- INBX
- Stock Information
- Founded
- WALD 1988
- INBX 2010
- Country
- WALD United States
- INBX United States
- Employees
- WALD N/A
- INBX N/A
- Industry
- WALD Package Goods/Cosmetics
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- WALD Consumer Discretionary
- INBX Health Care
- Exchange
- WALD Nasdaq
- INBX Nasdaq
- Market Cap
- WALD 306.3M
- INBX 345.8M
- IPO Year
- WALD 2021
- INBX 2020
- Fundamental
- Price
- WALD $1.81
- INBX $27.69
- Analyst Decision
- WALD Strong Buy
- INBX Hold
- Analyst Count
- WALD 5
- INBX 2
- Target Price
- WALD $4.96
- INBX N/A
- AVG Volume (30 Days)
- WALD 535.5K
- INBX 111.3K
- Earning Date
- WALD 11-11-2025
- INBX 11-13-2025
- Dividend Yield
- WALD N/A
- INBX N/A
- EPS Growth
- WALD N/A
- INBX N/A
- EPS
- WALD N/A
- INBX N/A
- Revenue
- WALD $273,868,000.00
- INBX $1,400,000.00
- Revenue This Year
- WALD $10.37
- INBX N/A
- Revenue Next Year
- WALD $14.37
- INBX N/A
- P/E Ratio
- WALD N/A
- INBX N/A
- Revenue Growth
- WALD 25.55
- INBX N/A
- 52 Week Low
- WALD $1.48
- INBX $10.81
- 52 Week High
- WALD $4.40
- INBX $30.23
- Technical
- Relative Strength Index (RSI)
- WALD 51.43
- INBX 58.85
- Support Level
- WALD $1.66
- INBX $26.82
- Resistance Level
- WALD $1.86
- INBX $28.86
- Average True Range (ATR)
- WALD 0.12
- INBX 1.39
- MACD
- WALD 0.04
- INBX -0.23
- Stochastic Oscillator
- WALD 75.58
- INBX 48.79
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.